137 related articles for article (PubMed ID: 8814234)
21. CD20 monoclonal antibodies decrease interleukin-4-stimulated expression of the low-affinity receptor for IgE (Fc epsilon RII/CD23) in human B cells by increasing the extent of its cleavage.
Bourget I; Di Berardino W; Breittmayer JP; Grenier-Brossette N; Plana-Prades M; Bonnefoy JY; Cousin JL
Eur J Immunol; 1995 Jul; 25(7):1872-6. PubMed ID: 7542593
[TBL] [Abstract][Full Text] [Related]
22. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
Gantner F; Hermann P; Nakashima K; Matsukawa S; Sakai K; Bacon KB
Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475
[TBL] [Abstract][Full Text] [Related]
23. Regulation of CD23 expression, soluble CD23 release and immunoglobulin synthesis of peripheral blood lymphocytes by glucocorticoids.
Fischer A; König W
Immunology; 1990 Dec; 71(4):473-9. PubMed ID: 2149121
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of human IgE production by a subset of anti-CD21 monoclonal antibodies: requirement of a co-signal to modulate epsilon transcripts.
Henchoz S; Gauchat JF; Aubry JP; Graber P; Pochon S; Bonnefoy JY
Immunology; 1994 Feb; 81(2):285-90. PubMed ID: 7512529
[TBL] [Abstract][Full Text] [Related]
25. 1alpha,25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro.
Heine G; Anton K; Henz BM; Worm M
Eur J Immunol; 2002 Dec; 32(12):3395-404. PubMed ID: 12432570
[TBL] [Abstract][Full Text] [Related]
26. Identification of a source of biologically active CD40 ligand.
Armitage RJ; Sato TA; Macduff BM; Clifford KN; Alpert AR; Smith CA; Fanslow WC
Eur J Immunol; 1992 Aug; 22(8):2071-6. PubMed ID: 1379186
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the promoter elements necessary for IL-4 and anti-CD40 antibody induction of murine Fc epsilon RII (CD23): comparison with the germline epsilon promoter.
Richards ML; Katz DH
J Immunol; 1997 Jan; 158(1):263-72. PubMed ID: 8977198
[TBL] [Abstract][Full Text] [Related]
28. IL-21 effects on human IgE production in response to IL-4 or IL-13.
Wood N; Bourque K; Donaldson DD; Collins M; Vercelli D; Goldman SJ; Kasaian MT
Cell Immunol; 2004; 231(1-2):133-45. PubMed ID: 15919378
[TBL] [Abstract][Full Text] [Related]
29. Induction of CD25 expression in human B lymphocytes by pharmacological activators of cellular signalling pathways.
McKay CE; Cushley W
Cytokine; 1996 Apr; 8(4):305-12. PubMed ID: 9162220
[TBL] [Abstract][Full Text] [Related]
30. Distinct modulation by interferon-gamma (IFN-gamma) of CD23 expression on B and T lymphocytes of atopic subjects.
Corominas M; Mestre M; Bas J; Buendia E
Clin Exp Immunol; 1998 May; 112(2):276-80. PubMed ID: 9649191
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of IL-13 by human B lymphocytes: regulation and role in IgE production.
Hajoui O; Janani R; Tulic M; Joubert P; Ronis T; Hamid Q; Zheng H; Mazer BD
J Allergy Clin Immunol; 2004 Sep; 114(3):657-63. PubMed ID: 15356573
[TBL] [Abstract][Full Text] [Related]
32. Leukotriene B4 enhances IL-4-induced IgE production from normal human lymphocytes.
Yamaoka KA; Dugas B; Paul-Eugene N; Mencia-Huerta JM; Braquet P; Kolb JP
Cell Immunol; 1994 Jun; 156(1):124-34. PubMed ID: 8200030
[TBL] [Abstract][Full Text] [Related]
33. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
34. Anti-CD23 monoclonal antibodies: comparisons of epitope specificities and modulating capacities for IgE binding and production.
Wakai M; Pasley P; Sthoeger ZM; Posnett DN; Brooks R; Hashimoto S; Chiorazzi N
Hybridoma; 1993 Feb; 12(1):25-43. PubMed ID: 7681036
[TBL] [Abstract][Full Text] [Related]
35. Modulation of IL-4-induced human IgE production in vitro by IFN-gamma and IL-5: the role of soluble CD23 (s-CD23).
Pène J; Chrétien I; Rousset F; Brière F; Bonnefoy JY; de Vries JE
J Cell Biochem; 1989 Mar; 39(3):253-64. PubMed ID: 2496134
[TBL] [Abstract][Full Text] [Related]
36. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.
Chen L; Overbergh L; Mathieu C; Chan LS
Clin Exp Allergy; 2008 Aug; 38(8):1367-80. PubMed ID: 18489026
[TBL] [Abstract][Full Text] [Related]
37. Regulation of human monocyte cell-surface and soluble CD23 (Fc epsilon RII) by granulocyte-macrophage colony-stimulating factor and IL-3.
Alderson MR; Tough TW; Ziegler SF; Armitage RJ
J Immunol; 1992 Aug; 149(4):1252-7. PubMed ID: 1386861
[TBL] [Abstract][Full Text] [Related]
38. Regulation by interleukin 2 of CD23 expression of leukemic and normal B cells: comparison with interleukin 4.
Hivroz C; Vallé A; Brouet JC; Banchereau J; Grillot-Courvalin C
Eur J Immunol; 1989 Jun; 19(6):1025-30. PubMed ID: 2526738
[TBL] [Abstract][Full Text] [Related]
39. Immunoregulatory role of CD40 in human B cell differentiation.
Splawski JB; Fu SM; Lipsky PE
J Immunol; 1993 Feb; 150(4):1276-85. PubMed ID: 7679424
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-4 and soluble CD23 serum levels in asthmatic atopic children.
Daher S; Santos LM; Solé D; De Lima MG; Naspitz CK; Musatti CC
J Investig Allergol Clin Immunol; 1995; 5(5):251-4. PubMed ID: 8574430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
